Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829699 · ClinicalTrials.gov registry record · Early Phase 1
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT00829699: Completed Early Phase 1 study, sponsored by University of Maryland, Baltimore.
NCT00829699 is a Early Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 31 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00829699, a Early Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about why patients with diabetes have increased heart attacks, strokes and other illnesses due to blood clots causing blockage of a blood vessel. The proposed protocol will study the separate and combined effects of high glucose and high fats on certain cardiovascular responses in Type 2 DM.
Interventions
- PROCEDURE euinsulinemic euglycemic glucose clamp
- PROCEDURE euinsulinemic hyperglycemic glucose clamp
- PROCEDURE Hyperinsulinemic euglycemic glucose clamp
- PROCEDURE Hyperinsulinemic hyperglycemic glucose clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2009-07 |
| Est. Completion | 2014-04 |
| Phase | Early Phase 1 |
What the finished NCT00829699 record still lists
NCT00829699 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 4 interventions - of which euinsulinemic euglycemic glucose clamp is the first listed.
NCT00829699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00829699 about?
NCT00829699 is a clinical study titled "Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus". The purpose of this study is to learn more about why patients with diabetes have increased heart attacks, strokes and other illnesses due to blood clots causing blockage of a blood vessel. The proposed protocol will study the separate and combined effects of high glucose and high fats on certain car...
What is the current status of trial NCT00829699?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2009-07. Estimated completion is 2014-04.
What interventions are being tested in trial NCT00829699?
The interventions under investigation include: euinsulinemic euglycemic glucose clamp (PROCEDURE), euinsulinemic hyperglycemic glucose clamp (PROCEDURE), Hyperinsulinemic euglycemic glucose clamp (PROCEDURE), Hyperinsulinemic hyperglycemic glucose clamp (PROCEDURE).
Who is sponsoring clinical trial NCT00829699?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00829699's enrollment target sits among peer trials
31 794th of 2000 higher than 1,195 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia